Please login to Zacks.com or register to post a comment.
| No Recent Quote currently available |
|
My Portfolio Tracker One of the most important steps you can take today is to set up your portfolio tracker on Zacks.com. Once you do, you'll be notified of major events affecting your stocks and/or funds with daily email alerts. Set yours up today. |
Zacks Rank Home - Evaluate your stocks and use the Zacks Rank to eliminate the losers and keep the winners.
Mutual Fund Rank Home - Evaluate your funds with the Mutual Fund Rank for both your personal and retirement funds.
Stock/Mutual Fund Screening - Find better stocks and mutual funds. The ones most likely to beat the market and provide a positive return.
My Portfolio - Track your Portfolio and find out where your stocks/mutual funds stack up with the Zacks Rank.
| Company Name | Symbol | %Change |
|---|---|---|
| SCIENTIFIC L | SCIL | 8.00% |
| NATUS MEDICA | BABY | 6.11% |
| SUMMER INFAN | SUMR | 6.02% |
| RADIANT LOGI | RLGT | 5.32% |
| NEW ORIENTAL | EDU | 4.51% |
Please login to Zacks.com or register to post a comment.
Resources
Client Support
Zacks Research is Reported On:
Zacks Investment Research
is an A+ Rated BBB
Accredited Business.
Copyright 2013 Zacks Investment Research
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1986 it has nearly tripled the S&P 500 with an average gain of +26% per year. These returns cover a period from 1986-2011 and were examined and attested by Baker Tilly, an independent accounting firm.
Visit performance for information about the performance numbers displayed above.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This page is temporarily not available. Please check later as it should be available shortly. If you have any questions, please email customer support at support@zacks.com or call 800-767-3771 ext. 9339.
The McGraw-Hill Companies Inc. ( ) recently announced that it has entered into an agreement with Apollo Global Management LLC ( APO - Snapshot Report ) to divest its education division for $2.5 billion.
The move is a strategic attempt on the company’s behalf to restructure its portfolio of businesses and concentrate more on high growth operations, thereby enhancing shareholder value through proper capital allocation.
The company expects to close the deal by the year end or early 2013 and will receive $250 million in senior unsecured notes, carrying an annual coupon of 8.5%.
What led to the Decision?
This company has been scrutinizing its business segments for sometime as it lost substantial market value over the last 5 years. To add to its woes, its rating agency was criticized for its decision to downgrade the U.S. economy. Further, the New York based hedge fund, Jana Partners and the Ontario Teachers' Pension Plan, were pushing the company to split into four separate organizations.
In addition, the company’s education division has been confronting shrinking revenues due to reduced spending on textbooks by the government. Further, the company is facing execution risk associated with its plans to develop its education division into a subscription-based model through digital delivery.
McGraw-Hill engaged The Goldman Sachs Group Inc. ( GS - Analyst Report ) and Evercore Partners Inc. ( EVR - Snapshot Report ) as the financial advisors to guide the company through the evaluation process.
Birth of McGraw-Hill Financial
McGraw-Hill stated that the company will be known as McGraw Hill Financial, upon the completion of the deal and will primarily focus on capital and commodities markets and will include iconic brands like S&P Ratings, S&P Capital IQ, S&P Indices, Platts and Commercial Markets.
The company added that it expects revenues of approximately $4.4 billion from McGraw-Financial in 2012 with approximately 40% of it coming from international avenues.
Moving ahead, McGraw-Hill expects to bear the impairment charges of approximately $450 million to $550 million in the fourth quarter of 2012 related to the sale. Moreover, the company will utilize the proceeds from sales (approximately $1.9 billion net of tax) to buyback shares, reduce short-term debt obligations and for strategic acquisitions.
Currently, we have a long-term 'Neutral' rating on McGraw-Hill, which competes with Pearson plc ( PSO - Snapshot Report ) . Moreover, the company holds a Zacks #3 Rank, which translates into a short-term ‘Hold’ recommendation.
Read the full reports :
Snapshot Report on PSO
Analyst Report on GS
Snapshot Report on APO
Snapshot Report on EVR